In vitro Activities of Nisin Alone or in Combination with Vancomycin and Ciprofloxacin against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Strains

被引:53
作者
Dosler, Sibel [1 ]
Gerceker, A. Alev [1 ]
机构
[1] Istanbul Univ, Fac Pharm, Dept Pharmaceut Microbiol, TR-34116 Istanbul, Turkey
关键词
Nisin; Staphylococcus aureus; Time-kill curve; Ciprofloxacin; Vancomycin; PEPTIDES; LANTIBIOTICS; BACTERIA;
D O I
10.1159/000335598
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We investigated the in vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant (MRSA) and -susceptible Staphylococcus aureus (MSSA) strains. Methods: The minimum inhibitory concentrations were determined by microbroth dilution technique. Antibiotic combinations were assessed using the checkerboard technique. The time-kill curve method was used for determining the bactericidal activity of nisin alone and in combination. Results: For both MSSA and MRSA strains, the minimum inhibitory concentrations of nisin ranged between 4 and 16 mg/l. With a fractional inhibitory concentration of >= 0.5 as borderline, synergistic interactions were seen in three of five isolates with nisin-ciprofloxacin compared to two of five isolates with nisin-vancomycin combinations against both MSSA and MRSA. No antagonism was observed. The results of time-kill curve analysis demonstrated concentration-dependent rapid bactericidal activity of nisin and synergism almost in all strains when nisin was used in combination with ciprofloxacin, and early synergistic interactions in some of the strains when it was used in combination with vancomycin. Conclusion: Nisin seems to be a good candidate for further investigations in the treatment of Gram-positive bacteria, alone or in combination with antibiotics. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:511 / 516
页数:6
相关论文
共 22 条
  • [1] [Anonymous], FED REG
  • [2] [Anonymous], 2012, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard
  • [3] The Vancomycin-Nisin(1-12) Hybrid Restores Activity against Vancomycin Resistant Enterococci
    Arnusch, Christopher J.
    Bonvin, Alexandre M. J. J.
    Verel, Anne Marie
    Jansen, Wouter T. M.
    Liskamp, Rob M. J.
    de Kruijff, Ben
    Pieters, Roland J.
    Breukink, Eefjan
    [J]. BIOCHEMISTRY, 2008, 47 (48) : 12661 - 12663
  • [4] Lantibiotics: Mode of Action, Biosynthesis and Bioengineering
    Bierbaum, G.
    Sahl, H. -G.
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2009, 10 (01) : 2 - 18
  • [5] Nisin, alone and combined with peptidoglycan-modulating antibiotics:: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci
    Brumfitt, W
    Salton, MRJ
    Hamilton-Miller, JMT
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (05) : 731 - 734
  • [6] Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI
  • [7] Clinical and Laboratory Standards Institute (CLSI), 1999, METHODS DETERMINING
  • [8] Antibiotic discovery in the twenty-first century: current trends and future perspectives
    Donadio, Stefano
    Maffioli, Sonia
    Monciardini, Paolo
    Sosio, Margherita
    Jabes, Daniela
    [J]. JOURNAL OF ANTIBIOTICS, 2010, 63 (08) : 423 - 430
  • [9] Epidemiology of methicillin-resistant Staphylococcus aureus
    Fluckiger, U
    Widmer, AF
    [J]. CHEMOTHERAPY, 1999, 45 (02) : 121 - 134
  • [10] In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics
    Giacometti, A
    Cirioni, O
    Barchiesi, F
    Scalise, G
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 38 (02) : 115 - 118